Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1. Development...
2 KB (88 words) - 01:40, 9 April 2023
Inebilizumab Maslimomab Morolimumab Ofatumumab Pexelizumab Reslizumab Rovelizumab Siplizumab Talizumab Telimomab aritox Teprotumumab Vapaliximab Vepalimomab...
7 KB (299 words) - 13:45, 27 April 2024
Gavilimomab Inolimomab Maslimomab Nerelimomab Odulimomab Telimomab aritox Vepalimomab Zolimomab aritox Chimeric Andecaliximab† Basiliximab Clenoliximab Galiximab...
38 KB (4,316 words) - 10:24, 26 August 2024
ulcerative colitis Veltuzumab mab humanized CD20 non-Hodgkin's lymphoma Vepalimomab mab mouse AOC3 (VAP-1) inflammation Vesencumab mab human NRP1 solid malignancies...
137 KB (4,083 words) - 21:25, 19 October 2024
Ventavis Ventolin Ventolin Hfa Ventolin Rotacaps Veopoz Veoza Veozah vepalimomab (INN) Vepesid veradoline (INN) veralipride (INN) verapamil (INN) Veraring...
9 KB (499 words) - 03:39, 25 September 2024
Gavilimomab Inolimomab Maslimomab Nerelimomab Odulimomab Telimomab aritox Vepalimomab Zolimomab aritox Chimeric Andecaliximab† Basiliximab Clenoliximab Galiximab...
2 KB (87 words) - 01:28, 30 May 2023
Inebilizumab Maslimomab Morolimumab Ofatumumab Pexelizumab Reslizumab Rovelizumab Siplizumab Talizumab Telimomab aritox Teprotumumab Vapaliximab Vepalimomab...
38 KB (2,656 words) - 12:11, 30 October 2023